Literature DB >> 1103627

Immunofluorescent studies of ocular cicatricial pemphigoid.

N Furey, C West, T Andrews, P D Paul, S F Bean.   

Abstract

Using direct and indirect immunofluorescent techniques, we studied ten patients with cicatricial pemphigoid (chronic cicatricial conjunctivitis). Serologic and histologic evaluation of 13 conjunctival, 12 mucous membrane, and 11 skin specimens from the ten patients showed that three had immunoglobulin deposition at the basement membrane zone of the conjunctiva. One patient had immunoglobulin deposited in the affected skin and oral mucosa. Two patients had circulating basement membrane zone antibodies that bound to their own tissue but not to guinea pig lip or human skin.

Entities:  

Mesh:

Year:  1975        PMID: 1103627     DOI: 10.1016/0002-9394(75)90278-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

Review 1.  Laboratory diagnosis of the allergic eye.

Authors:  M H Friedlaender; A Lee; R L Manka
Journal:  Clin Rev Allergy       Date:  1988

2.  Cicatricial pemphigoid.

Authors:  C S Foster
Journal:  Trans Am Ophthalmol Soc       Date:  1986

3.  The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation.

Authors:  W Bernauer; M J Elder; J N Leonard; P Wright; J K Dart
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

4.  HLA antigens in ocular cicatricial pemphigoid.

Authors:  B J Mondino; S I Brown; B S Rabin
Journal:  Br J Ophthalmol       Date:  1978-04       Impact factor: 4.638

5.  Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study.

Authors:  P A Frith; V A Venning; F Wojnarowska; P R Millard; A J Bron
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

Review 6.  [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis].

Authors:  E Schmidt; T Meyer-Ter-Vehn; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.174

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.